Immunis Closes $10 Million Financing Round
/PRNewswire/ -- Immunis Inc., a private biotechnology company developing a novel treatment for age and disease-related immune decline, has closed a $10M Series...
Source: prnewswire.com
Stay updated with breaking news from Screening Visit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Immunis Inc., a private biotechnology company developing a novel treatment for age and disease-related immune decline, has closed a $10M Series...
/PRNewswire/ -- Immunis Inc., a private biotechnology company developing a novel treatment for age and disease-related immune decline, has closed a $10M Series...
The University of Cambridge will pay participants £250 for the brain imaging study at Addenbrooke's Hospital.